CREO - CREO MEDICAL GROUP - Share Chat

Creo Medical Group is an AIM-listed medical device company specialising in advanced energy (microwave and RF) technologies for minimally invasive electrosurgery. Its proprietary CROMA Advanced Energy Platform powers a suite of devices, notably Speedboat Inject and Kamira (now Kairos), primarily targeting gastrointestinal (GI) endoscopy procedures for resection, dissection, and haemostasis.

The company’s strategy centres on improving patient outcomes through less invasive procedures, aiming to disrupt traditional surgical methods. Commercialisation is a key focus, driven by direct sales and strategic partnerships, including a significant global collaboration with Olympus. As a high-growth med-tech firm, Creo is heavily investing in research, development, and market expansion, positioning itself to capture a significant share of the expanding minimally invasive surgery market. It remains pre-profit, typical for innovative medical device companies in their commercialisation phase, with ongoing capital requirements for growth.